MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Analgesics Market" US to 2014
While sales of analgesics are increasing, the market is still up against a few challenges. A high degree of brand loyalty makes it difficult to get consumers to try new brands. Alternatively, opportunities for innovation present new usage occasions to grow market sales.
Table of Content
Scope and Themes
What you need to know
Definition
Data sources
Sales data
Consumer survey data
Abbreviations and terms
Abbreviations
Terms
Executive Summary
Overview
The market
Figure 1: Total US sales and fan chart forecast of OTC analgesics, at current prices, 2009-19
Segment performance
Figure 2: Sales of OTC analgesics segmented by type, 2012 and 2014
Key players
Figure 3: MULO sales of OTC analgesics, by leading companies, rolling 52 weeks 2013 and 2014
The consumer
Product usage
Figure 4: OTC analgesic usage, by age, March 2014
Figure 5: Reasons used OTC analgesics, March 2014
Purchase habits
Figure 6: Purchase behaviors, March 2014
Ways to incite trial
Figure 7: Interest in product innovations, March 2014
What we think
Issues and Insights
How can companies innovate in the analgesics category?
The issues
The implications
What opportunities are there to increase external analgesic use?
The issues
The implications
How will the aging population affect the OTC analgesic market?
The issues
The implications
Trend Applications
Trend: FSTR HYPR
Trend: Totophobia
Trend: Prepare for the Worst
Market Size and Forecast
Key points
Key brands return to shelf helps to boost OTC analgesic sales
Outlook for OTC analgesics positive
Sales and forecast of OTC analgesics
Figure 8: Total US sales and forecast of OTC analgesics, at current prices, 2009-19
Figure 9: Total US sales and forecast of OTC analgesics, at inflation-adjusted prices, 2009-19
Fan chart forecast
Figure 10: Total US sales and fan chart forecast of OTC analgesics, at current prices, 2009-19
Key points
Aging population increases need for pain relief
Figure 11: Population by age, 2009-19
Increased stress leads to headaches
High rates of exercise bode well for pain treatment
Figure 12: Regular exercise participation, by age, November 2012-December 2013
Effects of the ACA on OTC analgesics
Competitive Context
Key points
Alternative ways to treat pain
Figure 13: Ways to treat pain, by gender and age, March 2014
Segment Performance
Key points
Internal dominates market while external boasts strong growth rates
Figure 14: Sales of OTC analgesics, segmented by type, 2012 and 2014
Internal analgesics benefit from name brands returning to market
Figure 15: Sales of OTC internal analgesics, by product form, 2009-14
Figure 16: Total US sales and forecast of OTC internal analgesics, at current prices, 2009-19
External analgesics experience uptick
Figure 17: Sales of OTC external analgesics, by product form, 2009-14
Figure 18: Total US sales and forecast of OTC external analgesics, at current prices, 2009-19
Retail Channels
Key points
Most analgesic sales at “other” retail channels
Figure 19: #Targetrun print ad
Sales at drug stores slow
Potential for alternative shopping and delivery formats to rise
Sales of OTC analgesics, by channel
Figure 20: Total US retail sales of OTC analgesics, by channel, at current prices, 2009-14
Leading Companies
Key points
Brands coming back to shelf increases competition
Manufacturer sales of OTC analgesics
Figure 21: MULO sales of OTC analgesics, by leading companies, rolling 52 weeks 2013 and 2014
Manufacturer volume of select OTC analgesics
Figure 22: MULO sales and volume of select OTC internal analgesics, rolling 52 weeks 2013 and 2014
Brand Share – OTC Internal Analgesics
Key points
Brands returning to market boost internal analgesics, challenge private label
Despite new innovations and heaving marketing, Advil sales down
Manufacturer sales of OTC internal analgesics
Figure 23: MULO sales of OTC internal analgesics, by leading companies, rolling 52 weeks 2013 and 2014
Leading brands highly competitive
Figure 24: Key purchase measures for the top OTC internal analgesic brands, by household penetration, 52 weeks ending Dec. 30, 2012 (year ago) and Dec. 29, 2013 (current)
Advil and Tylenol top internal analgesic brand usage
Figure 25: Brands of headache and pain relievers used, by age, November 2012-December 2013
Brand Share – External Analgesics: Rubs
Key points
Icy Hot accounts for nearly a quarter of MULO sales
New introductions from Salonpas boosts category
Younger users driving segment
Manufacturer sales of external analgesic rubs
Figure 26: MULO sales of OTC external analgesic rubs, by leading companies, rolling 52 weeks 2013 and 2014
Icy Hot increases household penetration
Figure 27: Key purchase measures for the top OTC analgesic rubs brands, by household penetration, 52 weeks ending Dec. 30, 2012 (year ago) and Dec. 29, 2013 (current)
Icy Hot most used brand
Figure 28: Brands of nonprescription pain relieving rubs, liquids, and wraps, by age, November 2012-December 2013
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
E: sales@marketresearchreports.biz
While sales of analgesics are increasing, the market is still up against a few challenges. A high degree of brand loyalty makes it difficult to get consumers to try new brands. Alternatively, opportunities for innovation present new usage occasions to grow market sales.
Browse Full Report With Toc: http://www.marketresearchreports.biz/analysis-details/analgesics-us-june-2014
Table of Content
Scope and Themes
What you need to know
Definition
Data sources
Sales data
Consumer survey data
Abbreviations and terms
Abbreviations
Terms
Executive Summary
Overview
The market
Figure 1: Total US sales and fan chart forecast of OTC analgesics, at current prices, 2009-19
Segment performance
Figure 2: Sales of OTC analgesics segmented by type, 2012 and 2014
Key players
Figure 3: MULO sales of OTC analgesics, by leading companies, rolling 52 weeks 2013 and 2014
The consumer
Product usage
Figure 4: OTC analgesic usage, by age, March 2014
Figure 5: Reasons used OTC analgesics, March 2014
Purchase habits
Figure 6: Purchase behaviors, March 2014
Ways to incite trial
Figure 7: Interest in product innovations, March 2014
What we think
To Get Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/207655
Issues and Insights
How can companies innovate in the analgesics category?
The issues
The implications
What opportunities are there to increase external analgesic use?
The issues
The implications
How will the aging population affect the OTC analgesic market?
The issues
The implications
Trend Applications
Trend: FSTR HYPR
Trend: Totophobia
Trend: Prepare for the Worst
Market Size and Forecast
Key points
Key brands return to shelf helps to boost OTC analgesic sales
Outlook for OTC analgesics positive
Sales and forecast of OTC analgesics
Figure 8: Total US sales and forecast of OTC analgesics, at current prices, 2009-19
Figure 9: Total US sales and forecast of OTC analgesics, at inflation-adjusted prices, 2009-19
Fan chart forecast
Figure 10: Total US sales and fan chart forecast of OTC analgesics, at current prices, 2009-19
To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/207655
Market Drivers
Key points
Aging population increases need for pain relief
Figure 11: Population by age, 2009-19
Increased stress leads to headaches
High rates of exercise bode well for pain treatment
Figure 12: Regular exercise participation, by age, November 2012-December 2013
Effects of the ACA on OTC analgesics
Competitive Context
Key points
Alternative ways to treat pain
Figure 13: Ways to treat pain, by gender and age, March 2014
Segment Performance
Key points
Internal dominates market while external boasts strong growth rates
Figure 14: Sales of OTC analgesics, segmented by type, 2012 and 2014
Internal analgesics benefit from name brands returning to market
Figure 15: Sales of OTC internal analgesics, by product form, 2009-14
Figure 16: Total US sales and forecast of OTC internal analgesics, at current prices, 2009-19
External analgesics experience uptick
Figure 17: Sales of OTC external analgesics, by product form, 2009-14
Figure 18: Total US sales and forecast of OTC external analgesics, at current prices, 2009-19
Retail Channels
Key points
Most analgesic sales at “other” retail channels
Figure 19: #Targetrun print ad
Sales at drug stores slow
Potential for alternative shopping and delivery formats to rise
Sales of OTC analgesics, by channel
Figure 20: Total US retail sales of OTC analgesics, by channel, at current prices, 2009-14
Leading Companies
Key points
Brands coming back to shelf increases competition
Manufacturer sales of OTC analgesics
Figure 21: MULO sales of OTC analgesics, by leading companies, rolling 52 weeks 2013 and 2014
Manufacturer volume of select OTC analgesics
Figure 22: MULO sales and volume of select OTC internal analgesics, rolling 52 weeks 2013 and 2014
Brand Share – OTC Internal Analgesics
Key points
Brands returning to market boost internal analgesics, challenge private label
Despite new innovations and heaving marketing, Advil sales down
Manufacturer sales of OTC internal analgesics
Figure 23: MULO sales of OTC internal analgesics, by leading companies, rolling 52 weeks 2013 and 2014
Leading brands highly competitive
Figure 24: Key purchase measures for the top OTC internal analgesic brands, by household penetration, 52 weeks ending Dec. 30, 2012 (year ago) and Dec. 29, 2013 (current)
Advil and Tylenol top internal analgesic brand usage
Figure 25: Brands of headache and pain relievers used, by age, November 2012-December 2013
Brand Share – External Analgesics: Rubs
Key points
Icy Hot accounts for nearly a quarter of MULO sales
New introductions from Salonpas boosts category
Younger users driving segment
Manufacturer sales of external analgesic rubs
Figure 26: MULO sales of OTC external analgesic rubs, by leading companies, rolling 52 weeks 2013 and 2014
Icy Hot increases household penetration
Figure 27: Key purchase measures for the top OTC analgesic rubs brands, by household penetration, 52 weeks ending Dec. 30, 2012 (year ago) and Dec. 29, 2013 (current)
Icy Hot most used brand
Figure 28: Brands of nonprescription pain relieving rubs, liquids, and wraps, by age, November 2012-December 2013
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
E: sales@marketresearchreports.biz
